Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 3 completed trials

    Completion Rate
    100%(3/3)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 2/3
    1
    33%
    Not Applicable
    2
    67%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution3 total trials
    Phase 2/3Combined phases
    1(33.3%)
    N/ANon-phased studies
    2(66.7%)

    Highest Phase Reached

    Phase 2/3

    Trial Status & Enrollment

    Completion Rate

    100.0%

    3 of 3 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    3

    all time

    Status Distribution
    Completed(3)

    Detailed Status

    Completed3

    Development Timeline

    Analytics

    Development Status

    Total Trials
    3
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 2/31 (33.3%)
    N/A2 (66.7%)

    Trials by Status

    completed3100%

    Recent Activity

    0 active trials
    Showing 3 of 3
    completednot_applicable

    Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)

    NCT02986672
    completednot_applicable

    Calanus Oil Supplementation and Maximal Oxygen Uptake

    NCT02908828
    completedphase_2_3

    Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man

    NCT01193543

    Clinical Trials (3)

    Showing 3 of 3 trials
    NCT02986672Not Applicable

    Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)

    Completed
    NCT02908828Not Applicable

    Calanus Oil Supplementation and Maximal Oxygen Uptake

    Completed
    NCT01193543Phase 2/3

    Effect of Calanus Oli on Intra-abdominal Fat, Glucose Tolerance and Lipids in Man

    Completed

    All 3 trials loaded

    Drug Details

    Intervention Type
    Dietary supplement
    Total Trials
    3